The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Parsey Merdad | Director | Grant(A) | 14K | — | $0 |
| Jun 18, 2026 | Peterson Kristine | Director | Grant(A) | 14K | — | $0 |
| Jun 18, 2026 | Hohneker John | Director | Grant(A) | 14K | — | $0 |
| Jun 18, 2026 | Nolet Chris | Director | Grant(A) | 14K | — | $0 |
| Feb 2, 2026 | Kastenmayer James Paul | General Counsel | Grant(A) | 130K | — | $0 |
| Feb 2, 2026 | Yao Zhengbin | President and CEO, Director | Grant(A) | 550K | — | $0 |
| Feb 2, 2026 | Kung Winston | Chief Financial Officer | Grant(A) | 140K | — | $0 |
| Feb 2, 2026 | Lutzker Stuart | President of R&D, Director | Grant(A) | 150K | — | $0 |
| Feb 2, 2026 | LaChapelle Robin | Chief Operating Officer | Grant(A) | 130K | — | $0 |
| Dec 10, 2025 | HHLR Advisors, LTD. | 10% Owner | Sell(S) | 556K | $23.37 | $13.0M |
| Jul 11, 2025 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 2K | $2.28 | $5K |
| Jul 11, 2025 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 7K | $2.28 | $15K |
| Jul 11, 2025 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 3K | $2.28 | $6K |
| Jul 11, 2025 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 3K | — | $0 |
| Jul 11, 2025 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 7K | — | $0 |
| Jul 11, 2025 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 2K | — | $0 |
| Jun 18, 2025 | Nolet Chris | Director | Grant(A) | 16K | — | $0 |
| Jun 18, 2025 | Hohneker John | Director | Grant(A) | 16K | — | $0 |
| Jun 18, 2025 | Peterson Kristine | Director | Grant(A) | 16K | — | $0 |
| Jun 18, 2025 | Parsey Merdad | Director | Grant(A) | 16K | — | $0 |
| Apr 28, 2025 | Parsey Merdad | Director | Grant(A) | 28K | — | $0 |
| Feb 3, 2025 | Kastenmayer James Paul | General Counsel | Grant(A) | 102K | — | $0 |
| Feb 3, 2025 | Kung Winston | Chief Financial Officer | Grant(A) | 120K | — | $0 |
| Feb 3, 2025 | LaChapelle Robin | Chief Operating Officer | Grant(A) | 120K | — | $0 |
| Feb 3, 2025 | Lutzker Stuart | President of R&D, Director | Grant(A) | 120K | — | $0 |
| Feb 3, 2025 | Yao Zhengbin | President and CEO, Director | Grant(A) | 380K | — | $0 |
| Sep 19, 2024 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 2K | $2.28 | $6K |
| Sep 19, 2024 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 12K | $3.65 | $45K |
| Sep 19, 2024 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 7K | $2.28 | $16K |
| Sep 19, 2024 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 3K | $6.24 | $17K |
| Sep 19, 2024 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 3K | $2.28 | $7K |
| Sep 19, 2024 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 2K | — | $0 |
| Sep 19, 2024 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 3K | — | $0 |
| Sep 19, 2024 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 7K | — | $0 |
| Sep 19, 2024 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 12K | — | $0 |
| Sep 19, 2024 | LaChapelle Robin | Chief Operating Officer | Option exercise(M) | 3K | — | $0 |
| May 16, 2024 | Hohneker John | Director | Grant(A) | 30K | — | $0 |
| Apr 22, 2024 | Peterson Kristine | Director | Grant(A) | 29K | — | $0 |
| Jan 30, 2024 | HHLR Advisors, LTD. | 10% Owner | Conversion(C) | 313K | — | — |
| Jan 30, 2024 | HHLR Advisors, LTD. | 10% Owner | Buy(P) | 556K | $18.00 | $10.0M |
| Jan 30, 2024 | HHLR Advisors, LTD. | 10% Owner | Conversion(C) | 3.6M | — | — |
| Jan 30, 2024 | HHLR Advisors, LTD. | 10% Owner | Conversion(C) | 55.0M | — | $0 |
| Jan 30, 2024 | HHLR Advisors, LTD. | 10% Owner | Conversion(C) | 4.8M | — | $0 |
| Jan 30, 2024 | Healy James | Director | Conversion(C) | 1.3M | — | — |
| Jan 30, 2024 | Healy James | Director | Buy(P) | 444K | $18.00 | $8.0M |
| Jan 30, 2024 | Healy James | Director | Conversion(C) | 1.3M | — | — |
| Jan 30, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 470K | — | — |
| Jan 30, 2024 | Gordon Carl L | Director, 10% Owner | Buy(P) | 222K | $18.00 | $4.0M |
| Jan 30, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 470K | — | — |
| Jan 30, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 822K | — | — |
| Jan 30, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 822K | — | — |
| Jan 30, 2024 | Gordon Carl L | Director, 10% Owner | Buy(P) | 222K | $18.00 | $4.0M |
| Jan 30, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 470K | — | — |
| Jan 30, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 822K | — | — |
| Jan 30, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 470K | — | — |
| Jan 30, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 822K | — | — |
| Jan 30, 2024 | OrbiMed Asia GP IV, L.P. | Director, 10% Owner | Buy(P) | 222K | $18.00 | $4.0M |
| Jan 30, 2024 | OrbiMed Asia GP IV, L.P. | Director, 10% Owner | Buy(P) | 222K | $18.00 | $4.0M |
| Jan 30, 2024 | OrbiMed Asia GP IV, L.P. | Director, 10% Owner | Conversion(C) | 470K | — | — |
| Jan 30, 2024 | OrbiMed Asia GP IV, L.P. | Director, 10% Owner | Conversion(C) | 470K | — | — |
| Jan 30, 2024 | OrbiMed Asia GP IV, L.P. | Director, 10% Owner | Conversion(C) | 822K | — | — |
| Jan 30, 2024 | OrbiMed Asia GP IV, L.P. | Director, 10% Owner | Conversion(C) | 822K | — | — |
| Jan 30, 2024 | OrbiMed Asia GP IV, L.P. | Director, 10% Owner | Conversion(C) | 822K | — | — |
| Jan 30, 2024 | OrbiMed Asia GP IV, L.P. | Director, 10% Owner | Conversion(C) | 822K | — | — |
| Jan 30, 2024 | OrbiMed Asia GP IV, L.P. | Director, 10% Owner | Conversion(C) | 470K | — | — |
| Jan 30, 2024 | OrbiMed Asia GP IV, L.P. | Director, 10% Owner | Conversion(C) | 470K | — | — |
| Jan 25, 2024 | Jallal Bahija | Director | Grant(A) | 18K | — | $0 |
| Jan 25, 2024 | Nolet Chris | Director | Grant(A) | 18K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).